Rachel Yap Martens
CIK: 0002071589
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Exercise(M)Direct67.1K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Tax Payment(F)Direct35.8K shares at avg. $1.47$53K - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Units
193.7K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Award(A)DirectStock Option (Right to Buy)
290.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise(M) | 67,090 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment(F) | 35,826 | $1.47 | $52,664 | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award(A) Restricted Stock Units | 193,740 | - | - | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award(A) Stock Option (Right to Buy) | 290,620 | - | - | Direct |
1-4 of 4 transactions
About Martens Rachel Yap
Martens Rachel Yap (SEC CIK 0002071589) files insider reports with the SEC as SVP, Partnerships & Corp Strat of LEXICON PHARMACEUTICALS, INC. (LXRX).
Signal8 holds 3 ownership filings by Martens Rachel Yap (1 Form 3, 2 Form 4), filed between Jun 6, 2025 and Mar 3, 2026. Those filings report 4 transactions, from Feb 12, 2026 to Feb 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Martens Rachel Yap's filings is in THE WOODLANDS, TX.
Recent filings by Martens Rachel Yap
Other insiders filing for LEXICON PHARMACEUTICALS, INC. (LXRX)
- Swain Judith L, Director
- Sullivan Diane E., Director
- SOBECKI CHRISTOPHER J, Director
- Cheung Ivan, Director
- BARKER SAM L, Director
- Amouyal Philippe, Director